BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 26786982)

  • 1. Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's Disease.
    Taxonera C; Barreiro-de-Acosta M; Bastida G; Martinez-Gonzalez J; Merino O; García-Sánchez V; Gisbert JP; Marín-Jiménez I; López-Serrano P; Gómez-García M; Iglesias E; Lopez-Sanroman A; Chaparro M; Saro C; Bermejo F; Pérez-Carazo L; Plaza R; Olivares D; Alba C; Mendoza JL; Fernández-Blanco I
    J Crohns Colitis; 2016 Jun; 10(6):657-62. PubMed ID: 26786982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world Experience of Anti-tumor Necrosis Factor Therapy for Internal Fistulas in Crohn's Disease: A Retrospective Multicenter Cohort Study.
    Kobayashi T; Hishida A; Tanaka H; Nuki Y; Bamba S; Yamada A; Fujii T; Shinzaki S; Yokoyama Y; Yoshida A; Ozeki K; Ashizuka S; Kamata N; Nanjo S; Kakimoto K; Nakamura M; Matsui A; Yamauchi R; Takahashi S; Tomizawa T; Yoshino T; Hibi T
    Inflamm Bowel Dis; 2017 Dec; 23(12):2245-2251. PubMed ID: 29084079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T; Göke B; Sackmann M
    Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].
    Rozpondek P; Zwolińska-Wcisło M; Przybylska M; Mach T
    Przegl Lek; 2011; 68(9):602-5. PubMed ID: 22335009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for Crohn's perianal fistulas.
    Tozer P; Ng SC; Siddiqui MR; Plamondon S; Burling D; Gupta A; Swatton A; Tripoli S; Vaizey CJ; Kamm MA; Phillips R; Hart A
    Inflamm Bowel Dis; 2012 Oct; 18(10):1825-34. PubMed ID: 22223472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early surgery in Crohn's disease patients with entero-urinary fistulas: does it change the prognosis?
    Coelho R; Magro F; Silva M; Macedo G
    Scand J Gastroenterol; 2016; 51(6):679-83. PubMed ID: 26679346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The respective role of medical and surgical therapy for enterovesical fistula in Crohn's disease.
    Zhang W; Zhu W; Li Y; Zuo L; Wang H; Li N; Li J
    J Clin Gastroenterol; 2014 Sep; 48(8):708-11. PubMed ID: 24457944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genital fistulas in female Crohn's disease patients.: clinical characteristics and response to therapy.
    de la Poza G; López-Sanroman A; Taxonera C; Marín-Jimenez I; Gisbert JP; Bermejo F; Opio V; Muriel A
    J Crohns Colitis; 2012 Apr; 6(3):276-80. PubMed ID: 22405162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease--clinical observations from a tertiary Eastern European center.
    Bor R; Farkas K; Bálint A; Szucs M; Ábrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
    Scand J Gastroenterol; 2015 Feb; 50(2):182-7. PubMed ID: 25384713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience.
    Peyrin-Biroulet L; Salleron J; Filippi J; Reenaers C; Antunes O; Filipe V; Louis E; Hébuterne X; Roblin X
    J Crohns Colitis; 2016 May; 10(5):516-24. PubMed ID: 26802084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type of fistula determines response to infliximab in patients with fistulous Crohn's disease.
    Parsi MA; Lashner BA; Achkar JP; Connor JT; Brzezinski A
    Am J Gastroenterol; 2004 Mar; 99(3):445-9. PubMed ID: 15056083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAID.
    Amiot A; Setakhr V; Seksik P; Allez M; Treton X; De Vos M; Laharie D; Colombel JF; Abitbol V; Reimund JM; Moreau J; Veyrac M; Flourié B; Cosnes J; Lemann M; Bouhnik Y
    Am J Gastroenterol; 2014 Sep; 109(9):1443-9. PubMed ID: 25091063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined approach with biologics and surgery for enterocutaneous fistulas in Crohn's disease.
    Fries W; La Malfa G; Costantino G; Repici A; Mazziotti S; Navarra G
    Inflamm Bowel Dis; 2011 Feb; 17(2):671-3. PubMed ID: 20848472
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary fistulas in Crohn's disease.
    Talamini MA; Broe PJ; Cameron JL
    Surg Gynecol Obstet; 1982 Apr; 154(4):553-6. PubMed ID: 7064089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative treatment of anal fistulas in Crohn's disease.
    Hermann J; Eder P; Banasiewicz T; Kołodziejczak B; Łykowska-Szuber L
    ANZ J Surg; 2016 Mar; 86(3):148-51. PubMed ID: 26861622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG; Nieminen U; Sipponen T; Turunen U; Arkkila P; Färkkilä M
    Scand J Gastroenterol; 2013 May; 48(5):543-51. PubMed ID: 23477356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment of enterovesical fistulas in Crohn's disease.
    McNamara MJ; Fazio VW; Lavery IC; Weakley FL; Farmer RG
    Dis Colon Rectum; 1990 Apr; 33(4):271-6. PubMed ID: 2323275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of patients with Crohn's disease who discontinued infliximab therapy upon clinical remission.
    Papamichael K; Vande Casteele N; Gils A; Tops S; Hauenstein S; Singh S; Princen F; Van Assche G; Rutgeerts P; Vermeire S; Ferrante M
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1103-10. PubMed ID: 25478919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fistula response to methotrexate in Crohn's disease: a case series.
    Mahadevan U; Marion JF; Present DH
    Aliment Pharmacol Ther; 2003 Nov; 18(10):1003-8. PubMed ID: 14616166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Necrosis Factor Inhibitors May Have Limited Efficacy for Complex Perianal Fistulas Without Luminal Crohn's Disease.
    McCurdy JD; Parlow S; Dawkins Y; Samji K; Rhee GG; Oliveira L; Macdonald B; Sabri E; Murthy S
    Dig Dis Sci; 2020 Jun; 65(6):1784-1789. PubMed ID: 31642006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.